ArticleEndocrinology2024

The Human Intermediate Prolactin Receptor I-tail Contributes Breast Oncogenesis by Targeting Ras/MAPK Pathway.

Shanwei Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.